Pluripotent stem cell (PSC) research is an expanding field that has the potential to change the way human diseases are studied and treated. See More The ability to differentiate embryonic stem (ES) cells and induced pluripotent stem (iPS) cells to specific downstream cell types opens up new avenues for drug development and regenerative medicine. From generation of iPS cells to maintenance, differentiation, characterization, and cryopreservation of ES and iPS cells, see how you can "Maximize Your Pluripotential" with the most complete, defined system for ES and iPS cell culture. For help with your hPSC workflow decision making, use our infographics to find the right reagents for you.
Read this mini-review to learn more about Pluripotent Stem Cells.See Less
Explore These Resources
Injury Induces Endogenous Reprogramming and Dedifferentiation of Neuronal Progenitors to Multipotency
Investigators characterized dedifferentiating cells using several lineage-tracing strains and single-cell mRNA-seq, and they showed that Sox2 is required for initiating dedifferentiation and that inhibition of Ezh2 promoted multipotent progenitor expansion.ESC & iPSC News Volume 12.46, November 22, 2017. Read full issue at